NCT06205485 Neoadjuvant Chemotherapy, Excision And Observation vs Chemoradiotherapy For Rectal Cancer Status RECRUITING Phase PHASE3
NCT06139211 A Phase Ib/II Study Of JS015 Combination Therapy in Advanced Solid Tumors Status RECRUITING Phase PHASE1/PHASE2
NCT06124157 A Study Testing the Combination of Dasatinib or Imatinib to Chemotherapy Treatment With Blinatumomab for Children, Adolescents, and Young Adults With Philadelphia Chromosome Positive (Ph+) or ABL-Class Philadelphia Chromosome-Like (Ph-Like) B-cell Acute Lymphoblastic Leukemia (B-ALL) Status RECRUITING Phase PHASE2
NCT06028737 Total Neoadjuvant FLOT Chemotherapy in Locally Advanced Gastric and Gastroesophageal Junction Cancer Status RECRUITING Phase PHASE2/PHASE3
NCT06011772 EGF-Depleting Therapy CIMAvax-EGF in Combination With Standard Therapy for RAS- and BRAF Wild-Type Metastatic Colorectal Cancer Status ACTIVE_NOT_RECRUITING Phase EARLY_PHASE1
NCT05945823 Phase 2 Futibatinib in Combination With PD-1 Antibody Based Standard of Care in Solid Tumors Status ACTIVE_NOT_RECRUITING Phase PHASE2
NCT05891171 Study of AB598 Monotherapy and Combination Therapy in Participants With Advanced Cancers Status ACTIVE_NOT_RECRUITING Phase PHASE1
NCT05863195 Testing Pump Chemotherapy in Addition to Standard of Care Chemotherapy Versus Standard of Care Chemotherapy Alone for Patients With Unresectable Colorectal Liver Metastases: The PUMP Trial Status RECRUITING Phase PHASE3
NCT05843188 Study of Hydroxychloroquine With FOLFIRI and Bevacizumab in DTP-high Metastatic Colorectal Cancer Status ACTIVE_NOT_RECRUITING Phase PHASE2
NCT05727163 FOLFOX Via HAI Plus Intravenous Irinotecan With or Without Bevacizumab Versus Systemic FOLFOXIRI With or Without Bevacizumab in Initially Unresectable RAS-mutated CRLM Patients Status RECRUITING Phase PHASE2
NCT05714553 NUC-3373 in Combination With Other Agents in Patients With Advanced Solid Tumours Status TERMINATED Phase PHASE1/PHASE2
NCT05688215 Zimberelimab and Quemliclustat in Combination With Chemotherapy for the Treatment of Patients With Borderline Resectable and Locally Advanced Pancreatic Adenocarcinoma Status RECRUITING Phase PHASE1/PHASE2
NCT05678257 A Study of NUC-3373 in Combination With Other Agents in Patients With Colorectal Cancer Status TERMINATED Phase PHASE2
NCT05651594 Propranolol in Combination With Pembrolizumab and Standard Chemotherapy for the Treatment of Unresectable Locally Advanced or Metastatic Esophageal or Gastroesophageal Junction Adenocarcinoma Status RECRUITING Phase PHASE2
NCT05615012 A Study Investigating Interactions Between BMS-986322 and Rosuvastatin, Metformin and Methotrexate in Healthy Participants Status COMPLETED Phase PHASE1
NCT05568095 A Clinical Trial of a New Combination Treatment, Domvanalimab and Zimberelimab, Plus Chemotherapy, for People With an Upper Gastrointestinal Tract Cancer That Cannot be Removed With Surgery That Has Spread to Other Parts of the Body Status ACTIVE_NOT_RECRUITING Phase PHASE3
NCT05567835 A Study of Total Neoadjuvant Chemotherapy With FLOT VS Standard Perioperative FLOT in Patients With Gastric or GEJ Cancer Status TERMINATED Phase PHASE2
NCT05564377 Targeted Therapy Directed by Genetic Testing in Treating Patients With Locally Advanced or Advanced Solid Tumors, The ComboMATCH Screening Trial Status RECRUITING Phase PHASE2